1. Field of the Invention
The invention relates to various indicators for identifying reprocessed medical instruments. More particularly, the invention relates to the utilization of various inks for the identification of reprocessed medical instruments.
2. Description of the Related Art
Engineers specializing in the design and manufacture of medical instruments commonly attempt to improve upon previously existing medical instruments by enhancing the usage of these instruments. By improving the medical instrument, the possibility for user error is often drastically reduced. Through improved engineering, these engineers attempt to eliminate the gap between the best surgeon and the worst surgeon through careful product design. Similarly, they try to transform patient care through inventive product design. Many of their medical instruments are designed for minimally invasive procedures, resulting in quicker surgeries, lower risk of complications, less pain, shorter recovery time and lower costs.
The development of improved manufacturing techniques, advanced materials and concerns regarding contamination have led to the development of medical instruments designed for single use applications. For example, many laparoscopic devices, such as, surgical staplers and trocars, are designed as single use items that are intended to be immediately disposed of after use.
A recent trend in the medical community is reprocessing of single use medical instruments, by parties other than the original equipment manufacturer, instead of discarding them after use. During reprocessing, the medical instruments are disassembled, cleaned and sterilized. They are then reassembled for future use.
However, many of the medical instruments reprocessed for further use are specifically designed only for use during a single procedure. Consequently, the performance of the medical instruments decline after reprocessing, since the components making up the medical instrument are not adapted for multiple uses and will degrade in performance when used beyond their intended life span. For example, reprocessing of the cutting devices on trocars extends these devices beyond their intended mission life and may result in duller blades. A greater force, therefore, is needed to make an initial incision, causing more trauma to the patient. In addition, the use of greater force increases the potential for error during the surgical procedure.
The reprocessing itself can also cause serious problems. Some of the components of single use medical instruments cannot be reused. Thus, the reprocessor must manufacture these components. The third party reprocessors often do not satisfy the tolerances required for proper operation of the medical instruments as the third party reprocessors do not have the in-depth knowledge of the device application or design required to create proper replacement parts.
As reprocessing of medical instruments proliferates, it has become very difficult to identify if an item has in fact been reprocessed or if it is the original medical instrument delivered by the original manufacturer. Doctors usually do not even know if a medical instrument has been reprocessed, since the medical instrument is commonly unpacked prior to use by the doctor and any reprocessing notification is located on the packaging of the medical instrument. The FDA requires labeling of the reprocessed item with the new manufacturer information; however the medical instrument itself is not required to be marked permanently and a removable tag is allowed. In fact, some hospitals instruct the staff responsible for opening medical instruments and setting up the medical instruments for surgery not to inform the doctor as to whether the medical instruments have been reprocessed.
Often, when these medical instruments have been reprocessed and used for a second, third or fourth time, they fail and are returned to the original product manufacturer, for example, assignee Ethicon Endo Surgery, Inc., of the present invention. The original manufacturers are commonly obligated to replace defective products (i.e., those original medical instruments which are defective and have not been reprocessed) and have them returned for analysis. However, there is no economical way to distinguish between a product that failed as a result of some defect in the original manufacture thereof and one that failed because of third party reprocessing.
It is, therefore, an object of the present invention to provide a medical instrument. The medical instrument includes a medical instrument body and a label including an indicator of exposure to fluids or solvents applied to the medical instrument body.
It is also an object of the present invention to provide a medical instrument wherein the indicator is a water soluble ink incorporated into material composition of the label.
It is another object of the present invention to provide a medical instrument wherein the indicator is a film printed with inks providing an indication of reuse or reprocessing of the medical instrument.
It is a further object of the present invention to provide a medical instrument wherein the film is a clear film and includes a first surface that is exposed for viewing when the label is applied to the medical instrument body and a second surface that faces the medical instrument body, and ink is printed upon the second surface which is not visible until contact with a fluid.
It is also an object of the present invention to provide a medical instrument wherein a mechanism is provided in the label for exposing the ink on the second surface to fluid when the medical instrument is in contact with a fluid.
It is another object of the present invention to provide a medical instrument wherein the label is opaque and includes a first surface which is exposed for viewing upon application to the medical instrument body and a second surface which faces the medical instrument body and hidden from view, and adhesive bonds the second surface to medical instrument in a manner permitting release of the label upon exposure to fluid revealing markings applied to the surface of the medical instrument.
It is a further object of the present invention to provide a medical instrument wherein the indicator is an indicator symbol composed of reactive ink such that the reactive ink turns color when exposed to various processing environments.
It is also an object of the present invention to provide a medical instrument wherein the indicator symbol includes section marked with reactive ink, and each section is printed with a unique reactive ink.
It is another object of the present invention to provide a medical instrument wherein a color scale is provided near each indicator ink that shows a user an expected color when the reactive ink does turn color.
It is a further object of the present invention to provide a medical instrument wherein the label is positioned on or around a seam of the medical instrument body.
It is also an object of the present invention to provide a medical instrument wherein the seam includes an underlying graphics image which is revealed upon removal of the label.
It is another object of the present invention to provide a medical instrument wherein the indicator includes a top printing layer and an opaque background printed using soluble inks. A message is printed beneath the top printing layer and the background, the message being composed of permanent inks, such that when reprocessed, the top printing layer and the background are removed exposing the message.
It is a further object of the present invention to provide a medical instrument wherein the label includes trace amounts of uniquely detectable chemicals or compounds such that when present they can be detected by analytical equipment.
It is also an object of the present invention to provide a medical instrument wherein the label includes a top layer and a base layer, and the top layer delaminates from the base layer upon exposure fluid.
It is another object of the present invention to provide a medical instrument wherein the base layer includes a message.
It is a further object of the present invention to provide a medical instrument wherein the top layer and base layer are optically interactive.
It is also an object of the present invention to provide a medical instrument wherein the indicator is a permanent ink which changes color after a period of time to indicate time of exposure.
It is another object of the present invention to provide a medical instrument wherein the indicator is an absorptive material sensitive to specific substances.
It is a further object of the present invention to provide a medical instrument a medical instrument body, a medical instrument component connected to the medical instrument body, and wherein the component is made from a material which changes color upon contact with fluid.
It is also an object of the present invention to provide a medical instrument wherein the component is a handle trigger or an actuator mechanism.
Other objects and advantages of the present invention will become apparent from the following detailed description when viewed in conjunction with the accompanying drawings, which set forth certain embodiments of the invention.
The detailed embodiment of the present invention is disclosed herein. It should be understood, however, that the disclosed embodiment is merely exemplary of the invention, which may be embodied in various forms. Therefore, the details disclosed herein are not to be interpreted as limiting, but merely as a basis for teaching one skilled in the art how to make and/or use the invention.
Since it is necessary to understand the underlying techniques currently employed in reprocessing medical instruments to gain a complete understanding of the present invention, the following discussion presents an overview of the techniques currently employed in the processing of medical instruments. Reprocessing generally relates to the preparation of medical instruments for further use. In particular, the preparation is commonly applied to single-use medical instruments and involves two major steps. The first is the cleaning stage and involves the removal of any foreign material from an item during reprocessing. The second step is sterilization and involves killing any living material, namely, any bacteria or virus, that could potentially contaminate a medical instrument.
Regardless of the reprocessing indicator technique employed in accordance with the present invention, it must fulfill certain criteria. In particular, the indicator technique must be applicable to a variety of single-use medical instruments, which vary in function, shape and size. The presence and location of the indicator should be known only to trained employees of the original manufacturer such that the original manufacturer may readily identify these items when they are returned based upon failures. In accordance with a preferred embodiment, it is contemplated neither the hospital staff nor administration should be aware of the indicator. The indicator could also be readily discernable to all hospital medical staff where such identification is desired. As medical instruments are commonly subjected to gamma radiation, the indication method employed in accordance with the present invention must be immune to gamma radiation and the indicator must be safe to any person in contact with the medical instrument during any part of the device's life. Further, the indicator should not surpass a critical level of bio-burden so as to not prevent effective sterilization levels being achieved and the indicator must be cost effective.
In accordance with a first embodiment, and with reference to
It is contemplated the water sensitive ink 12 is utilized in conjunction with a major component of the medical instrument (for example, the trigger handle 14 of a surgical stapler 10 as shown with reference to
In accordance with another embodiment, and with reference to
The embodiment shown with reference to
In accordance with a preferred embodiment, the water-soluble ink 112 is chosen such that it becomes adulterated when exposed to typical solutions used in medical instrument cleaning processes such as water, enzymatic or alkaline detergents, liquid sterilants (such as Cidex, marketed by Johnson & Johnson Advanced Sterilization Products or other liquid).
The label 114 used in accordance with a preferred embodiment and as shown with reference to
In accordance with another embodiment as shown with reference to
When the label 214 is applied to a medical instrument 210, liquid coming into contact with the label 214 is allowed to flow under the clear film 218 making contact with the water-soluble ink 212 printed upon the second surface 222 by flowing along the back (or second) surface 222 of the clear film 218. The flow of liquids into contact with the water-soluble ink 212 may be accomplished in a number of manners as shown with reference to
Referring to the embodiment shown with reference to
Referring to
In addition, and in accordance with a preferred embodiment of the present invention as shown with reference to
More particularly, the label 414 of the embodiment shown with reference to
In accordance with yet another embodiment of the present invention and with reference to
More particularly, the opaque label 514 is constructed in a manner similar to the label 114, 214 disclosed with reference to the embodiments of
In order to ensure penetration of fluid solvent to the second surface 522 for interaction with the adhesive 524 in a manner releasing the label 514 from the medical instrument 510 for exposing the markings 538 applied to the surface of the medical instrument 510, adhesive 524 is applied only along the perimeter of the top film 518 and perforations, holes 528 or laterally oriented channels (see
In accordance with yet another embodiment, and with reference to
While the indicator symbol 640 is disclosed herein as being printed directly on the medical instrument, it is contemplated the indicator symbol may be printed upon or otherwise integrated into an adhesive backed printed label which is secured to the body of the medical instrument. In accordance with a preferred embodiment, the indicator symbol 640 takes the form of a circle subdivided into pie shaped wedge sections 642 with each section printed with a unique reactive ink 612 for reacting to specific exposure of processing fluids to indicate to which processing fluids the medical instrument has been exposed. Each of the pie shaped wedge sections 642 of the circle would be for unrelated process indicator reactive inks 612 and so on until the indicator pie shaped wedge sections 642 are all used. The reactive inks 612, when exposed to the environmental condition or process of chemical exposure, turn color to indicate that the medical instrument 610 saw that particular condition in its life.
It is further contemplated that it is desirable to provide a color scale 644 near each indicator reactive ink 612 that shows a user of the present invention what the expected color is when it does turn color. In accordance with a preferred embodiment, the scale is a border around the indicator symbol 640 (see
It is further contemplated the actual shape of the indicator symbol may be other than a circle. As such, the indicator symbol may be of various shapes determined to be conducive to the particular device. In addition, it is contemplated the various indicator inks and specific markings may be varied to suit the specific application for which the medical instrument is intended to be used and environments to which the medical instrument may be exposed
In accordance with yet a further embodiment, and with reference to
The label or band 714 is applied in a recessed area 748 provided that it does not and cannot be removed intact. Once broken or cut the label or band 714 falls off completely thus removing any desired information so as to differentiate an original manufacturer's medical instrument 710 from one disassembled and reworked (see
In accordance with yet another embodiment as disclosed with reference to
More particularly, the label 814 for such an embodiment includes a clear film 818 including a first surface 820 exposed to the environment once the label 814 is applied to the medical instrument 810 and second surface 822 facing the medical instrument 810 (and therefore hidden) once the label 814 is applied to the medical instrument 810. The trademarks and other company graphics 852, 854 are printed on the first surface 820 of the label 814 that becomes degraded by exposure to cleaning processes used in reprocessing medical instruments 810. The second surface 822 of the label 814 is printed with a warning message, for example, REPROCESSED, such that once the trademark or other company graphics 852, 854 printed upon the first surface 820 are degraded by exposure to cleaning processes used in the reprocessing of the medical instrument 810, the warning message is exposed (see
In accordance with another embodiment, and with reference to
Following such a cleaning process as shown with reference to
It is contemplated the specific coatings 914 used in accordance with this embodiment would be of a composition that is soluble in water or other specific solutions that a used medical instrument 910 would be subject to in a cleaning process. They could include DNA containing solutions, monoclonal antibodies or other specialized chemicals that are considered safe for human contact and that provide a unique fingerprint for later analysis so that there is no question as to their origin or when they are and are not present.
In accordance with another embodiment, and with reference to
In accordance with an alternate embodiment as shown with reference to
In yet another embodiment, and with reference to
In accordance with yet a further embodiment, and with reference to
In accordance with a preferred embodiment, the absorptive material 1370 is trapped inside two clear flexible pieces of plastic 1372, 1374 allowing for clear visualization thereof. The two pieces of plastic 1372, 1374 are joined together in such a way as to create a pathway allowing fluids to migrate into contact with the absorptive material 1370. In accordance with a preferred embodiment, this pathway is created by ultrasonically welding the two pieces of plastic 1372, 1374 together around the periphery excluding a region. The unwelded region(s) 1376 would then function as the pathway for fluids. The trapped absorptive material 1370 is affixed to medical instruments 1310 using either an adhesive or second tack-welding process 1324 (or similar materials). During use, fluids (carbon dioxide, water and/or biological fluids) would contact the absorptive material 1370 either changing its color, shape, size or other feature (see
Another method of detecting prior use of medical instruments is to have a coating of material sensitive to carbon dioxide applied to the medical instrument. Examples of appropriate materials can be found within patents, such as U.S. Pat. No. 4,728,499, which is incorporated herein by reference, and generally constitute a material that changes color during and after exposure. The material is applied to the medical instrument during the assembly process using an adhesive or friction.
For example, when this technique is applied to trocars as disclosed with reference to
Thermochromic ink now currently available in the marketplace may be utilized for medical instrument labeling in accordance with the present invention. The Thermochromic ink described herein appears transparent, or a specific color, when applied, but when exposed to a heat above a specific temperature for a minimum specific time the ink becomes very apparent, or changes in color in apparent manner. As shown below the word REUSED on the labeling does not appear until the handle has gone through decontamination, hot washing or re-sterilization process thereby informing the user that the medical instrument is being reused. Also if the medical instrument fails during its reuse when it is sent to the original manufacturer for inspection, the manufacturer can document that it was during reuse that the failure occurred.
While the preferred embodiments have been shown and described, it will be understood that there is no intent to limit the invention by such disclosure, but rather, is intended to cover all modifications and alternate constructions falling within the spirit and scope of the invention.
Number | Name | Date | Kind |
---|---|---|---|
2578150 | Rathke | Dec 1951 | A |
2654170 | Nestor | Oct 1953 | A |
3311084 | Edenbaum | Mar 1967 | A |
3592682 | Weiner et al. | Jul 1971 | A |
3702511 | Miller | Nov 1972 | A |
3835564 | Gottschalk | Sep 1974 | A |
3891242 | Arnold et al. | Jun 1975 | A |
4049121 | White | Sep 1977 | A |
4082873 | Williams | Apr 1978 | A |
4444839 | Dudzik et al. | Apr 1984 | A |
4479838 | Dunsirn et al. | Oct 1984 | A |
4614367 | Breen | Sep 1986 | A |
4718553 | Adamoli et al. | Jan 1988 | A |
4837061 | Smits et al. | Jun 1989 | A |
4846504 | MacGregor et al. | Jul 1989 | A |
4994314 | Rosenfeld et al. | Feb 1991 | A |
5042842 | Green et al. | Aug 1991 | A |
5060848 | Ewan | Oct 1991 | A |
5329713 | Lundell | Jul 1994 | A |
5411295 | Bates et al. | May 1995 | A |
5451372 | Larsson et al. | Sep 1995 | A |
5569163 | Francis et al. | Oct 1996 | A |
5622764 | Battles | Apr 1997 | A |
5633058 | Hoffer et al. | May 1997 | A |
5660925 | Cooley et al. | Aug 1997 | A |
5779686 | Sato et al. | Jul 1998 | A |
5895075 | Edwards | Apr 1999 | A |
6220633 | Van Boom et al. | Apr 2001 | B1 |
6238623 | Amhof et al. | May 2001 | B1 |
6447014 | Seidl | Sep 2002 | B1 |
6455119 | Carides et al. | Sep 2002 | B2 |
6575919 | Reiley et al. | Jun 2003 | B1 |
6659036 | Omatsu et al. | Dec 2003 | B2 |
6828018 | Waterbury et al. | Dec 2004 | B2 |
7105225 | Birkholz et al. | Sep 2006 | B2 |
7185601 | Carpenter et al. | Mar 2007 | B2 |
7287691 | Montanari | Oct 2007 | B2 |
7732046 | LaBrosse et al. | Jun 2010 | B2 |
7744997 | Birkholz et al. | Jun 2010 | B2 |
7892639 | Mess et al. | Feb 2011 | B2 |
8037545 | McLaughlin | Oct 2011 | B2 |
8360323 | Widzinski et al. | Jan 2013 | B2 |
8440274 | Wang | May 2013 | B2 |
20020066219 | Weidman et al. | Jun 2002 | A1 |
20030211618 | Patel | Nov 2003 | A1 |
20040210167 | Webster | Oct 2004 | A1 |
20050036719 | Wu et al. | Feb 2005 | A1 |
20050113808 | Berndt | May 2005 | A1 |
20060025814 | Hatori | Feb 2006 | A1 |
20060054526 | Dean et al. | Mar 2006 | A1 |
20060069305 | Couvillon et al. | Mar 2006 | A1 |
20060236913 | Wills | Oct 2006 | A1 |
20070130811 | Shevelev et al. | Jun 2007 | A1 |
20070215001 | Voegele | Sep 2007 | A1 |
20070219563 | Voegele | Sep 2007 | A1 |
Number | Date | Country |
---|---|---|
WO2004114256 | Dec 2004 | WO |
Number | Date | Country | |
---|---|---|---|
20090266289 A1 | Oct 2009 | US |